B-CELL LYMPHOMAS

Clinical trials for B-CELL LYMPHOMAS explained in plain language.

Never miss a new study

Get alerted when new B-CELL LYMPHOMAS trials appear

Sign up with your email to follow new studies for B-CELL LYMPHOMAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1

New combo therapy aims to boost remission in Hard-to-Treat lymphoma

Disease control Not yet recruiting

This phase 2 trial tests whether a combination of the targeted drug glofitamab with chemotherapy (gemcitabine and oxaliplatin) can improve the effectiveness of a CAR-T cell therapy called lisocabtagene maraleucel in people with relapsed or refractory aggressive B-cell lymphomas. …

Matched conditions: B-CELL LYMPHOMAS

Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control

Last updated Jul 19, 2026 00:00 UTC

B-CELL LYMPHOMAS

Get alerted when new B-CELL LYMPHOMAS trials appear

New combo therapy aims to boost remission in Hard-to-Treat lymphoma